Trivalent cocktail of de novo designed immunogens enables the robust induction and focusing of functional antibodies in vivo
Sesterhenn, F.; Yang, C.; Cramer, J.; Bonet, J.; Wen, X.; Abriata, L.; Kucharska, I.; Chiang, C.-I.; Wang, Y.; Castoro, G.; Vollers, S.; Galloux, M.; Charles-Adrien, R.; Rosset, S.; Corthesy, P.; Georgeon, S.; Villard, M.; Descamps, D.; Rameix-Welti, M.-A.; Mas, V.; Ervin, S.; Eleouet, J.-f.; Riffault, S.; Bates, J.; Julien, J.-P.; Li, Y.; Jardetzky, T. S.; Krey, T.; Correia, B.
Show abstract
De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a novel protein design algorithm, termed TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. Both in mice and non-human primates, cocktails of three de novo designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused pre-existing antibody responses towards defined neutralization epitopes. Overall, our de novo design approach opens the possibility of targeting specific epitopes for vaccine and therapeutic antibody development, and more generally will be applicable to design de novo proteins displaying complex functional motifs.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structural insights for neutralization of BA.1 and BA.2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody 96%
- Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities 96%
- Structural mapping of antibody landscapes to human betacoronavirus spike proteins 95%
Similar papers in this journal
- From sequence to scaffold: computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks 97%
- A general approach for selection of epitope-directed binders to proteins 95%
- Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.